SCIENTIFIC POSTER: Validation of Novel Continuous Live-Cell Assays for Immune Cell Activation and Killing of Blood Cell Cancers
The blood cancers leukaemia, lymphoma and myeloma are expected to cause the deaths of > 55,000 people in the US in 2017. New immunological approaches afford great promise for improved therapies. Here, we describe novel high throughput live-cell image-based assays for immune cell activation and killing of blood cancer cells that are geared towards screening for new treatments for these malignancies.
The data examples illustrate how continuous live-cell analysis can be used with suspension cells, to provide both additional biological insight (full time-courses, clustering information, morphology) and enhanced productivity (automation, miniaturisation) compared to other techniques. Download the poster to learn how this approach will be a valuable addition to the technology toolbox for academic and industrial immuno-oncology researchers.
Learn more about Sartorius solutions for CAR-T Discovery & Development at www.sartorius.com/car-t-research.